Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.
about
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroOxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprimIneffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia.In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy.In vitro selection of resistant Helicobacter pylori.Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacinResistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis.Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers.Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.Quinolone antimicrobial agents: adverse effects and bacterial resistance.Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin.Norfloxacin: clinical pharmacology and clinical use.In vitro selection of bacteria resistant to LY146032, a new cyclic lipopeptideActivity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compoundPurification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli.In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.Development of resistance to ciprofloxacin in nutrient-rich and nutrient-limited growth conditions in vitro by Pseudomonas aeruginosa isolates from patients with cystic fibrosis.In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents.Assessment of altered binding specificity of bacteriophage for ciprofloxacin-induced antibiotic-resistant Salmonella Typhimurium.In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.Studies on the development and stability of resistance of Helicobacter pylori to metronidazole and clarithromycin.Cross-resistance and cross-susceptibility between fluoroquinolone agents.Development of Pseudomonas aeruginosa resistance to norfloxacin during therapy.The place of quinolones in antibacterial therapy in hospitals.In vitro activity of enoxacin compared with norfloxacin and amikacin.Studies on the emergence of resistance to lomefloxacin in vitro.ThermotolerantCampylobacterduring Broiler Rearing: Risk Factors and Intervention
P2860
Q24670241-5AA489BE-5974-409D-9ED1-30F6671637A8Q24676621-1AEC704F-DDAB-48D0-8D5A-938DBFEECE37Q24677059-00F04945-A6FF-4573-8876-262BFF0556E8Q33978398-232A489D-7F86-4586-8F0C-3E6E4FE32053Q34431842-64DF9BA0-97EB-47E5-858A-9A86262D9451Q35243584-4B95C9F0-4CD2-4ACF-8AFC-1654C48B9168Q35271542-225D1289-1A06-438D-B2B6-1740A59D2211Q35319641-383BB276-D1BF-47A7-B928-93F9156FA32BQ35543537-C93A8525-2F8D-4D9E-BEF6-1646A45C14D1Q35543768-5662216B-1776-498C-926C-D91DABF5B4F5Q35640867-054CC59A-5E44-426E-A161-7DF1E7EF4D09Q35757560-CC3ABEF2-BF11-4ECC-99F8-EF1F35C9B8FAQ35760862-BE39ACDC-69A7-4FC6-9DAF-3C62B6A07D5FQ35821472-1CEAB1F0-E088-445F-B3A7-3E8624C4017EQ38322827-68BE3A53-8E3E-4F69-8E71-014F590D37E0Q39476728-5A0DF346-C26C-4293-B71F-389A629DF546Q39681144-2153DB85-0B2B-496A-8C4C-51F30A4A28BFQ39817448-956EC502-9AD2-48F1-8E69-DCA555C70F19Q39828033-80EB9506-DC8C-4A90-8274-6158711514CCQ39832267-E0D107EC-337E-4514-8A08-93CE99C60640Q39835001-631839D0-755F-48F6-8F52-9F1B3F51329DQ39850428-D66FD96B-0FE8-4F1E-A051-341F2DD3BD52Q39851107-9AB54EE3-9391-4CE0-9E66-C58BE9782470Q39851366-233946D4-9B30-4FC1-BDFC-A48F5BD4008EQ40088425-27DC761E-C624-4751-B0DF-1B861140DA1FQ40283581-0E008C5E-680A-4DA5-B5FF-F8AC5A2A46DFQ40746752-E3B7B89D-BD3E-416E-8773-D88CD8881518Q41858315-C1CB41E0-B2CE-4DBC-B51C-43D405890A8FQ43593183-5397B9EB-9027-48EE-941C-42159FC73AA9Q54284522-321BD23D-EFEB-4EF1-B0EB-7D39F837B6EEQ54375847-9C4F63CA-4DAA-487B-8CA8-D9E097AAE250Q54432495-7B06E299-D2D7-4B0A-9FC3-AA8D4E222CFFQ54455847-A2217EEC-8A80-454D-B352-66F5066B7BEBQ54727002-9607DA8D-599A-4737-8163-1B2639E57A3AQ57986009-E5A215B4-988C-4315-8D00-D3A25D5366FE
P2860
Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Rapid selection of organisms w ...... ations of norfloxacin in agar.
@ast
Rapid selection of organisms w ...... ations of norfloxacin in agar.
@en
type
label
Rapid selection of organisms w ...... ations of norfloxacin in agar.
@ast
Rapid selection of organisms w ...... ations of norfloxacin in agar.
@en
prefLabel
Rapid selection of organisms w ...... ations of norfloxacin in agar.
@ast
Rapid selection of organisms w ...... ations of norfloxacin in agar.
@en
P2093
P2860
P356
P1476
Rapid selection of organisms w ...... ations of norfloxacin in agar.
@en
P2093
Chippendale GR
P2860
P304
P356
10.1128/AAC.23.1.188
P407
P577
1983-01-01T00:00:00Z